Patents by Inventor Clive King

Clive King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230348388
    Abstract: Provided are methods of producing Active Pharmaceutical Ingredient (API) grade migalastat hydrochloride, and for purifying intermediate grade migalastat hydrochloride. Further provided are methods of producing [(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride (lucerastat hydrochloride) and other 1-deoxygalactonojirimycin compounds, as well as methods of purifying intermediate grade lucerastat hydrochloride and other 1-deoxygalactonojirimycin compounds.
    Type: Application
    Filed: June 26, 2023
    Publication date: November 2, 2023
    Applicant: Amicus Therapeutics, Inc.
    Inventors: Kamlesh Sheth, Sergey Tesler, James Cartwright, Clive King, Wendy Cross
  • Patent number: 11685718
    Abstract: Provided are methods of producing Active Pharmaceutical Ingredient (API) grade migalastat hydrochloride, and for purifying intermediate grade migalastat hydrochloride. Further provided are methods of producing [(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride (lucerastat hydrochloride) and other 1-deoxygalactonojirimycin compounds, as well as methods of purifying intermediate grade lucerastat hydrochloride and other 1-deoxygalactonojirimycin compounds.
    Type: Grant
    Filed: December 15, 2021
    Date of Patent: June 27, 2023
    Assignee: Amicus Therapeutics, inc.
    Inventors: Kamlesh Sheth, Sergey Tesler, James Cartwright, Clive King, Wendy Cross
  • Patent number: 11623916
    Abstract: Provided are methods of producing a batch of 1,2,3,6-tetrapivaloyl-D-galactofuranoside; 5-azido-5-deoxy-1,2,3,6-tetrapivaloyl-D-galactofuranoside; intermediate grade migalastat hydrochloride; and/or migalastat hydrochloride. Also provided are methods of determining the purity of a batch of 1,2,3,6-tetrapivaloyl-D-galactofuranoside; 5-azido-5-deoxy-1,2,3,6-tetrapivaloyl-D-galactofuranoside; intermediate grade migalastat hydrochloride; and/or migalastat hydrochloride. Also provided are methods of distributing a batch of 1,2,3,6-tetrapivaloyl-D-galactofuranoside; 5-azido-5-deoxy-1,2,3,6-tetrapivaloyl-D-galactofuranoside; intermediate grade migalastat hydrochloride; and/or migalastat hydrochloride. Also provided are methods of assessing suitability of migalastat hydrochloride for medical use.
    Type: Grant
    Filed: January 14, 2021
    Date of Patent: April 11, 2023
    Assignee: Amicus Therapeutics, Inc.
    Inventors: Kamlesh Sheth, Sergey Tesier, James Cartwright, Clive King, Wendy Cross
  • Publication number: 20100174567
    Abstract: Apparatus (1) for enabling temporary access to a wheelchair (15) comprises a number of wheelchair containers (2) and a control unit (5) which communicates with the containers and is arranged to interact with a user to permit release of the wheelchair from the container. Each container may be provided with a reader (16) for an identifier (17) carried by a wheelchair, so that the control unit can record that a wheelchair with that identifier has been released, and record return of that or another wheelchair to the container. The control unit may communicate with the control units of other apparatus at other locations, and/or with a central data processing facility (39). The system may be integrated with a transport reservation system.
    Type: Application
    Filed: October 1, 2007
    Publication date: July 8, 2010
    Applicant: WWB SERVICES LIMITED
    Inventors: Anthony Clive King, Barbara Ann King, Matthew Lievesley